Andriy Goy was appointed to the position of Technical Director. He has 15 years’ experience of working with the Company.
Andriy Goy started his career at the Company back in 2001 as an Engineer of Quality Assurance Department. In 2002, he was promoted to the Leading Engineer of the same department, and in January 2004, he headed the Validation Department. Since the beginning of 2012, he has been holding the position of Head of Research and Development Department.
Andriy Goy’s scientific and practical interests cover the following areas:
Since 2004, Andriy Goy has been a member of international associations such as ISPE, PDA, AAPS and others.
For your reference, Grygoriy Kostiuk, who previously headed the Technical Directorate, resigned his position in late June and became a member of the Company’s Supervisory Board.
The pharmaceutical company JSC “Farmak” considers the possibility of launching the manufacture of products, in particular, diagnostic test kits, to combat coronavirus spread. “Now we analyse the possibility of arranging the release of supportive care products, disinfectants and antiseptics, diagnostic test kits, protective medical products, including masks, ...
Farmak reinvests 95% of its profits in the development. “We have never paid more than 5% of our profits as dividends. We have reinvested everything in the development. Due to this, Farmak’s capitalization can be estimated at $850 million to $1 billion today. If I sell the shares that I hold, I will earn a […]
The Memorandum is aimed at developing the mutual cooperation in the implementation of the state programs of the Republic of Uzbekistan for the further development of the national pharmaceutical industry. “We know the Uzbek market well and we are committed to develop cooperation. Farmak has been present in Uzbekistan since 2004. The residents of this [&hellip...